找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Radiopharmaceutical Therapy; Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex

[復(fù)制鏈接]
查看: 46802|回復(fù): 61
樓主
發(fā)表于 2025-3-21 16:15:02 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Radiopharmaceutical Therapy
編輯Lisa Bodei,Jason S. Lewis,Brian M. Zeglis
視頻videohttp://file.papertrans.cn/821/820888/820888.mp4
概述First book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
圖書封面Titlebook: Radiopharmaceutical Therapy;  Lisa Bodei,Jason S. Lewis,Brian M. Zeglis Book 2023 The Editor(s) (if applicable) and The Author(s), under ex
描述.This book covers foundational topics in the emerging field of radiopharmaceutical therapy. It?is divided into three sections: fundamentals, deeper dives, and special topics. In the first section, the authors examine the field from a bird’s-eye view, covering topics including the history of radiopharmaceutical therapy, the radiobiology of radiopharmaceutical therapy, and the radiopharmaceutical chemistry of both metallic and non-metallic radionuclides. The second section provides a more in-depth look at specific radiotherapeutics. Chapters include broader discussions of the different platforms for radiopharmaceutical therapy as well as more focused case studies covering individual radiotherapeutics. The third and final section explores a number of areas for further study, including medical physics, artificial intelligence,?.in vivo?.pretargeting, theranostic imaging, and the regulatory review process for radiotherapeutics..This book is the first of its kind andis useful for a broad audience of scientists, researchers, physicians, and students across a range of fields, including biochemistry, cancer biology, nuclear medicine, radiology, and radiation oncology..
出版日期Book 2023
關(guān)鍵詞radiotherapy; cancer therapy; endoradiotherapy; radiopharmaceutical chemistry; Radiotherapeutics; Radioim
版次1
doihttps://doi.org/10.1007/978-3-031-39005-0
isbn_softcover978-3-031-39772-1
isbn_ebook978-3-031-39005-0
copyrightThe Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
The information of publication is updating

書目名稱Radiopharmaceutical Therapy影響因子(影響力)




書目名稱Radiopharmaceutical Therapy影響因子(影響力)學(xué)科排名




書目名稱Radiopharmaceutical Therapy網(wǎng)絡(luò)公開度




書目名稱Radiopharmaceutical Therapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Radiopharmaceutical Therapy被引頻次




書目名稱Radiopharmaceutical Therapy被引頻次學(xué)科排名




書目名稱Radiopharmaceutical Therapy年度引用




書目名稱Radiopharmaceutical Therapy年度引用學(xué)科排名




書目名稱Radiopharmaceutical Therapy讀者反饋




書目名稱Radiopharmaceutical Therapy讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:31:39 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:50:12 | 只看該作者
978-3-031-39772-1The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl
地板
發(fā)表于 2025-3-22 04:52:31 | 只看該作者
Lisa Bodei,Jason S. Lewis,Brian M. ZeglisFirst book of its kind of to cover radiopharmaceutical therapy.Comprehensive and accessible introduction to a rapidly-growing field.Useful for a broad audience of scientists, researchers, physicians,
5#
發(fā)表于 2025-3-22 09:07:33 | 只看該作者
The Production of Therapeutic Radionuclidesh the decay of long-lived radionuclides such as .U, .Th, and .U, upon which chemically distinct daughters can be separated for incorporation into radiopharmaceuticals. The rate of the production of a given radionuclide depends on the cross section of the nuclear reaction on the target material, the
6#
發(fā)表于 2025-3-22 13:41:48 | 只看該作者
7#
發(fā)表于 2025-3-22 17:46:55 | 只看該作者
8#
發(fā)表于 2025-3-23 00:06:59 | 只看該作者
9#
發(fā)表于 2025-3-23 05:23:38 | 只看該作者
Case Study #3: Antibody Fragments in Radiopharmaceutical Therapylity, unfavorable tissue distribution, and reduced binding affinity of radiolabeled antibody fragments have inhibited their widespread application in radiopharmaceutical therapy. In response, a great deal of effort has been dedicated to optimize the pharmacokinetics of antibody fragments (especially
10#
發(fā)表于 2025-3-23 06:38:13 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 18:14
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
元氏县| 沈阳市| 青冈县| 特克斯县| 西华县| 广宗县| 集安市| 西华县| 崇阳县| 康马县| 太谷县| 丹东市| 泰兴市| 修水县| 深圳市| 武陟县| 贵港市| 鹤峰县| 南昌市| 颍上县| 建湖县| 临汾市| 平罗县| 于都县| 通化县| 永城市| 抚顺县| 沾化县| 平乡县| 洪江市| 隆德县| 吴江市| 昆山市| 牡丹江市| 新蔡县| 濮阳县| 佛山市| 黎平县| 香港 | 浦东新区| 阿图什市|